Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Leonid Timashev
RBC
Leonid Timashev
RBC Capital
Wall Street Analyst
★★★☆☆
#1376
on 13Foresight · ranked by our own returns
50%
Success Rate
-3.3%
Average Return
14 of 28 calls profitable · -4.5% vs benchmark
📈 Across the calls we could measure, roughly 50% of Leonid Timashev's ratings turned a profit when each position was held for 1 year — averaging -3.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

228 Buy 35 Hold 0 Sell
Leonid's Stock Coverage 26 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
EWTX
Edgewise Therapeutics
 Jun 17, 2026 BUY Strong Buy
+22.4% avg upside
14 analysts
$59.00
60.21% Upside
 ·
PRAX
Praxis Precision Medicines
 Jun 17, 2026 BUY Strong Buy
+91.5% avg upside
24 analysts
$449.00
59.07% Upside
 +0.0%
ALKS
Alkermes
 Jun 08, 2026 BUY Strong Buy
-17.6% avg upside
34 analysts
$56.00
24.51% Upside
 +6.8%
INSM
Insmed
 Jun 05, 2026 BUY Strong Buy
+82.2% avg upside
36 analysts
$195.00
103.60% Upside
 +4.5%
ADCT
ADC Therapeutics
 Jun 03, 2026 HOLD Buy
+450.4% avg upside
12 analysts
$2.00
83.47% Upside
 -66.6%
ONC
BeOne Medicines
 Jun 02, 2026 BUY Strong Buy
+28.4% avg upside
28 analysts
$436.00
61.37% Upside
 -4.4%
RVMD
Revolution Medicines
 Jun 02, 2026 BUY Strong Buy
-12.3% avg upside
32 analysts
$182.00
11.73% Upside
 +4.3%
LEGN
Legend Biotech
 Jun 01, 2026 BUY Strong Buy
+140.3% avg upside
27 analysts
$64.00
129.22% Upside
 +40.6%
BHVN
Biohaven Ltd.
 May 28, 2026 BUY Strong Buy
+87.5% avg upside
25 analysts
$22.00
62.12% Upside
 +32.5%
DSGN
Design Therapeutics
 May 18, 2026 BUY Strong Buy
+45.3% avg upside
9 analysts
$20.00
60.74% Upside
 ·
CRMD
Cormedix
 May 14, 2026 BUY Strong Buy
+73.5% avg upside
13 analysts
$14.00
61.56% Upside
 +7.7%
JSPR
Jasper Therapeutics
 May 14, 2026 HOLD Strong Buy
+6361.2% avg upside
17 analysts
$3.00
562.23% Upside
 -50.9%
PYXS
Pyxis Oncology
 May 14, 2026 BUY Strong Buy
+240.3% avg upside
13 analysts
$5.00
146.26% Upside
 -14.0%
CMPS
COMPASS Pathways
 May 13, 2026 BUY Strong Buy
+63.6% avg upside
18 analysts
$22.00
75.58% Upside
 +8.9%
CATX
Perspective Therapeutics
 May 11, 2026 BUY Strong Buy
+280.3% avg upside
22 analysts
$14.00
374.50% Upside
 -24.5%
CGON
CG Oncology, Inc.
 May 08, 2026 BUY Strong Buy
+41.1% avg upside
17 analysts
$81.00
32.64% Upside
 -12.3%
VSTM
Verastem
 May 07, 2026 BUY Strong Buy
+260.2% avg upside
23 analysts
$15.00
264.01% Upside
 -29.3%
JAZZ
Jazz Pharmaceuticals
 May 06, 2026 BUY Strong Buy
-1.8% avg upside
35 analysts
$258.00
14.77% Upside
 +0.9%
NAMS
NewAmsterdam Pharma Company
 May 06, 2026 BUY Strong Buy
+56.4% avg upside
18 analysts
$47.00
57.61% Upside
 -3.7%
EXEL
Exelixis
 May 06, 2026 HOLD Strong Buy
-21.0% avg upside
33 analysts
$43.00
17.21% Downside
 +9.1%
CYTK
Cytokinetics
 May 05, 2026 BUY Strong Buy
+8.9% avg upside
36 analysts
$119.00
51.09% Upside
 +2.5%
IDYA
IDEAYA Biosciences
 May 05, 2026 BUY Strong Buy
+55.2% avg upside
29 analysts
$53.00
69.76% Upside
 +8.5%
AXSM
Axsome Therapeutics
 May 05, 2026 BUY Strong Buy
-10.5% avg upside
28 analysts
$302.00
20.65% Upside
 +12.9%
XNCR
Xencor
 May 05, 2026 BUY Strong Buy
+159.9% avg upside
27 analysts
$19.00
50.22% Upside
 -12.3%
NUVB
Nuvation Bio
 May 04, 2026 BUY Strong Buy
+132.2% avg upside
15 analysts
$20.00
259.78% Upside
 +20.9%
BCYC
Bicycle Therapeutics
 Apr 30, 2026 HOLD Strong Buy
+505.6% avg upside
20 analysts
$5.00
25.08% Upside
 -7.6%
🔒 21 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Leonid Timashev — Frequently Asked Questions
How accurate are Leonid Timashev's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Leonid's ratings were profitable over a one-year hold, with an average return of -3.3% per rating, or -4.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Leonid ranked on 13Foresight?
Leonid Timashev is currently ranked #1376 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Leonid cover?
Leonid most recently has ratings on EWTX, PRAX, ALKS, INSM, ADCT, ONC, RVMD, LEGN, BHVN, DSGN, CRMD, JSPR and 14 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.